SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Laaksonen Lauri)
 

Sökning: WFRF:(Laaksonen Lauri) > Effects of dexmedet...

  • Nummela, Aleksi J.Department of Peri-operative Services, Intensive Care and Pain Medicine, Turku University Hospital, Finland ; Department of Internal Medicine, Turku University Hospital, Finland (författare)

Effects of dexmedetomidine, propofol, sevoflurane and S-ketamine on the human metabolome : A randomised trial using nuclear magnetic resonance spectroscopy

  • Artikel/kapitelEngelska2022

Förlag, utgivningsår, omfång ...

  • Wolters Kluwer,2022
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:his-20791
  • https://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-20791URI
  • https://doi.org/10.1097/EJA.0000000000001591DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • CC BY 4.0September 15, 2021Correspondence to Aleksi J. Nummela, Department of Internal Medicine, Turku University Hospital, 20521 Turku, Finland E-mail: aljunu@utu.fiFinancial support and sponsorship: this work was supported by Academy of Finland, Helsinki, Finland (grant numbers 266467, 266434); Jane and Aatos Erkko Foundation, Helsinki, Finland; The Finnish Medical Foundation, Helsinki, Finland (JWL); The Emil Aaltonen Foundation, Tampere, Finland (JWL); and The Paulo Foundation, Espoo, Finland (LTL) and Orion Research Foundation, Espoo, Finland (LTL); Signe and Ane Gyllenberg Foundation, Helsinki, Finland (KJV); The Finnish Medical Foundation, Eero Matti Raninen Fund, Helsinki, Finland (AJN) and University of Turku, Finland (AJN).
  • BACKGROUND: Pharmacometabolomics uses large-scale data capturing methods to uncover drug-induced shifts in the metabolic profile. The specific effects of anaesthetics on the human metabolome are largely unknown.OBJECTIVE: We aimed to discover whether exposure to routinely used anaesthetics have an acute effect on the human metabolic profile.DESIGN: Randomised, open-label, controlled, parallel group, phase IV clinical drug trial.SETTING: The study was conducted at Turku PET Centre, University of Turku, Finland, 2016 to 2017.PARTICIPANTS: One hundred and sixty healthy male volunteers were recruited. The metabolomic data of 159 were evaluable.INTERVENTIONS: Volunteers were randomised to receive a 1-h exposure to equipotent doses (EC50 for verbal command) of dexmedetomidine (1.5 ng ml-1; n = 40), propofol (1.7 μg ml-1; n = 40), sevoflurane (0.9% end-tidal; n = 39), S-ketamine (0.75 μg ml-1; n = 20) or placebo (n = 20).MAIN OUTCOME MEASURES: Metabolite subgroups of apolipoproteins and lipoproteins, cholesterol, glycerides and phospholipids, fatty acids, glycolysis, amino acids, ketone bodies, creatinine and albumin and the inflammatory marker GlycA, were analysed with nuclear magnetic resonance spectroscopy from arterial blood samples collected at baseline, after anaesthetic administration and 70 min postanaesthesia.RESULTS: All metabolite subgroups were affected. Statistically significant changes vs. placebo were observed in 11.0, 41.3, 0.65 and 3.9% of the 155 analytes in the dexmedetomidine, propofol, sevoflurane and S-ketamine groups, respectively. Dexmedetomidine increased glucose, decreased ketone bodies and affected lipoproteins and apolipoproteins. Propofol altered lipoproteins, fatty acids, glycerides and phospholipids and slightly increased inflammatory marker glycoprotein acetylation. Sevoflurane was relatively inert. S-ketamine increased glucose and lactate, whereas branched chain amino acids and tyrosine decreased.CONCLUSION: A 1-h exposure to moderate doses of routinely used anaesthetics led to significant and characteristic alterations in the metabolic profile. Dexmedetomidine-induced alterations mirror α2-adrenoceptor agonism. Propofol emulsion altered the lipid profile. The inertness of sevoflurane might prove useful in vulnerable patients. S-ketamine induced amino acid alterations might be linked to its suggested antidepressive properties.TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02624401. URL: https://clinicaltrials.gov/ct2/show/NCT02624401.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Laaksonen, Lauri T.Department of Peri-operative Services, Intensive Care and Pain Medicine, Turku University Hospital, Finland ; Turku PET Centre, University of Turku and Turku University Hospital, Finland (författare)
  • Laitio, Timo T.Department of Peri-operative Services, Intensive Care and Pain Medicine, Turku University Hospital, Finland (författare)
  • Kallionpää, Roosa E.Department of Peri-operative Services, Intensive Care and Pain Medicine, Turku University Hospital, Finland ; Department of Psychology and Speech-Language Pathology and Turku Brain and Mind Center, University of Turku, Finland (författare)
  • Långsjö, Jaakko W.Department of Intensive Care, Tampere University Hospital, Finland (författare)
  • Scheinin, Joonas M.Department of Peri-operative Services, Intensive Care and Pain Medicine, Turku University Hospital, Finland (författare)
  • Vahlberg, Tero J.Department of Clinical Medicine, Biostatistics, University of Turku and Turku University Hospital, Finland (författare)
  • Koskela, Harri T.Nightingale Health Ltd, Helsinki, Finland (författare)
  • Aittomäki, ViljamiNightingale Health Ltd, Helsinki, Finland (författare)
  • Valli, Katja J.,1973-Högskolan i Skövde,Institutionen för biovetenskap,Forskningsmiljön Systembiologi,Department of Peri-operative Services, Intensive Care and Pain Medicine, Turku University Hospital, Finland ; Department of Psychology and Speech-Language Pathology and Turku Brain and Mind Center, University of Turku, Finland,Kognitiv neurovetenskap och filosofi, Consciousness and Cognitive Neuroscience(Swepub:his)vala (författare)
  • Revonsuo, AnttiHögskolan i Skövde,Institutionen för biovetenskap,Forskningsmiljön Systembiologi,Department of Psychology and Speech-Language Pathology and Turku Brain and Mind Center, University of Turku, Finland,Kognitiv neurovetenskap och filosofi, Consciousness and Cognitive Neuroscience(Swepub:his)reva (författare)
  • Niemi, MikkoDepartment of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Finland ; Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Finland (författare)
  • Perola, MarkusFinnish Institute for Health and Welfare, Finland ; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Finland (författare)
  • Scheinin, HarryDepartment of Peri-operative Services, Intensive Care and Pain Medicine, Turku University Hospital, Finland ; Turku PET Centre, University of Turku and Turku University Hospital, Finland ; Integrative Physiologyand Pharmacology, Institute of Biomedicine, University of Turku, Finland (författare)
  • Department of Peri-operative Services, Intensive Care and Pain Medicine, Turku University Hospital, Finland ; Department of Internal Medicine, Turku University Hospital, FinlandDepartment of Peri-operative Services, Intensive Care and Pain Medicine, Turku University Hospital, Finland ; Turku PET Centre, University of Turku and Turku University Hospital, Finland (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:European Journal of Anaesthesiology: Wolters Kluwer39:6, s. 521-5320265-02151365-2346

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy